Intravitreal Aflibercept Outcomes in Patients with Persistent Macular Exudate Previously Treated with Bevacizumab and/or Ranibizumab for Neovascular Age-Related Macular Degeneration

Saved in:
Bibliographic Details
Main Authors: David R. Griffin, Preston P. Richmond, John C. Olson
Format: Article
Language:English
Published: Wiley 2014-01-01
Series:Journal of Ophthalmology
Online Access:http://dx.doi.org/10.1155/2014/497178
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832549859160227840
author David R. Griffin
Preston P. Richmond
John C. Olson
author_facet David R. Griffin
Preston P. Richmond
John C. Olson
author_sort David R. Griffin
collection DOAJ
format Article
id doaj-art-6b6e228a14c14ba1b1aeced975d67bc5
institution Kabale University
issn 2090-004X
2090-0058
language English
publishDate 2014-01-01
publisher Wiley
record_format Article
series Journal of Ophthalmology
spelling doaj-art-6b6e228a14c14ba1b1aeced975d67bc52025-02-03T06:08:26ZengWileyJournal of Ophthalmology2090-004X2090-00582014-01-01201410.1155/2014/497178497178Intravitreal Aflibercept Outcomes in Patients with Persistent Macular Exudate Previously Treated with Bevacizumab and/or Ranibizumab for Neovascular Age-Related Macular DegenerationDavid R. Griffin0Preston P. Richmond1John C. Olson2The University of Central Florida College of Medicine, 6850 Lake Nona Boulevard, Orlando, FL 32827, USACentral Florida Retina and the Macular Degeneration Center, 44 Lake Beauty Drive, Suite 300, Orlando, FL 32806, USACentral Florida Retina and the Macular Degeneration Center, 44 Lake Beauty Drive, Suite 300, Orlando, FL 32806, USAhttp://dx.doi.org/10.1155/2014/497178
spellingShingle David R. Griffin
Preston P. Richmond
John C. Olson
Intravitreal Aflibercept Outcomes in Patients with Persistent Macular Exudate Previously Treated with Bevacizumab and/or Ranibizumab for Neovascular Age-Related Macular Degeneration
Journal of Ophthalmology
title Intravitreal Aflibercept Outcomes in Patients with Persistent Macular Exudate Previously Treated with Bevacizumab and/or Ranibizumab for Neovascular Age-Related Macular Degeneration
title_full Intravitreal Aflibercept Outcomes in Patients with Persistent Macular Exudate Previously Treated with Bevacizumab and/or Ranibizumab for Neovascular Age-Related Macular Degeneration
title_fullStr Intravitreal Aflibercept Outcomes in Patients with Persistent Macular Exudate Previously Treated with Bevacizumab and/or Ranibizumab for Neovascular Age-Related Macular Degeneration
title_full_unstemmed Intravitreal Aflibercept Outcomes in Patients with Persistent Macular Exudate Previously Treated with Bevacizumab and/or Ranibizumab for Neovascular Age-Related Macular Degeneration
title_short Intravitreal Aflibercept Outcomes in Patients with Persistent Macular Exudate Previously Treated with Bevacizumab and/or Ranibizumab for Neovascular Age-Related Macular Degeneration
title_sort intravitreal aflibercept outcomes in patients with persistent macular exudate previously treated with bevacizumab and or ranibizumab for neovascular age related macular degeneration
url http://dx.doi.org/10.1155/2014/497178
work_keys_str_mv AT davidrgriffin intravitrealafliberceptoutcomesinpatientswithpersistentmacularexudatepreviouslytreatedwithbevacizumabandorranibizumabforneovascularagerelatedmaculardegeneration
AT prestonprichmond intravitrealafliberceptoutcomesinpatientswithpersistentmacularexudatepreviouslytreatedwithbevacizumabandorranibizumabforneovascularagerelatedmaculardegeneration
AT johncolson intravitrealafliberceptoutcomesinpatientswithpersistentmacularexudatepreviouslytreatedwithbevacizumabandorranibizumabforneovascularagerelatedmaculardegeneration